Kymriah (tisagenlecleucel)

pCPA File Number: 22470

Negotiation Status:

Active Negotiation

Indication(s):

Follicular lymphoma (FL), Relapsed or refractory, grade 1, 2 or 3a, in adult patients after two or more lines of systemic therapy

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

PG0306-000

pCPA Engagement Letter Issued:

2024-12-04

Negotiation Process Concluded:

Not Applicable